The Duloxetine Delayed-Release Capsules' voluntary recall began on Oct. 10 after the FDA deemed the medication the ...
Some bottles of the antidepressant duloxetine, sold under the brand name Cymbalta, were recalled due to the presence of a ...
Release Capsules - sold under the brand name Cymbalta - have been recalled due to containing a potentially cancer-causing ...
Duloxetine Delayed-Release Capsules were recalled because the pills may contain high levels of a cancer-causing chemical.
The Federal Drug Administration issued a recall on Tuesday for a common medicine for depression. Over 7,000 bottles of ...
The US Food and Drug Administration has recalled thousands of bottles of Duloxetine antidepressant, saying it contained high ...
The U.S. Food and Drug Administration updated the risk level of a recalled antidepressant due to the product containing high ...
Now, the FDA is assigning the second-highest risk level to the recall of Duloxetine Delayed-Release Capsules, produced by ...
The U.S. Food and Drug Administration is urging patients not to stop taking their prescribed medication if it falls under the ...
Purpose: The pharmacology, pharmacokinetics, efficacy, safety, drug interactions, dosage and administration, cost, and place in therapy of duloxetine for major depression, pain from diabetic ...
For diabetic peripheral neuropathic pain, the recommended dosage is 60 mg per day, although dosages of up to 120 mg daily have been studied. [25] Higher dosages do not have proven benefit and may ...